Login
Who's Online
We have 101 guests and no members online
Statistics
- Users 5518
- Articles 732
- Articles View Hits 17057574
Why Use This Site for Advertisement?
Thank you for your interest in advertising on Gene Therapy Net. The website is active since January 2008 and the site's traffic grows day by day (see statistics). The visitors of Gene Therapy Net are professionals, doctors and researchers, as well as students, patients, regulatory affairs officers, government policy officers, and everyone else interested in gene therapy. |
|
Gene Therapy Net is run by a policy officer in the clinical gene therapy trial assessment procedure in the Netherlands. He has a scientific background in molecular biology and immunology. The website is a non-governmental, personal initiative and is aimed to provide comprehensive and accurate information about gene therapy, clinical trials, research news, and relevant gene therapy regulation and legislation. |
Advertisement Opportunities
Full banners, cube banners and text ads will be placed on highly visible sections throughout the site. Cube banners and text ads are placed in the left columns of the site, whereas full banners are placed in the middle wide column of the site. Your banner or text ad will be hyperlinked to the web address of your choice.
There are four different types of campaigns:
1 | Full banner | Located in rotation with other banners on all pages, including the home page |
2 | Home page banner or text links | Located only on the home page. Always visible in 1st or 2nd news item in center of the home page |
3 | Cube banner | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
4 | Text links | Located on left ‘related links’ column on a minimum of 50% of all pages, including the home page |
Advertisement Rates
We suggest a minimum of 3 months or at least 10,000 impressions, but please keep in mind that these rates and time lengths are not set in stone, but rather displayed to give you an idea on how our ad pricing is usually structured. By advertising on Gene Therapy Net, you agree to our terms and conditions listed below.
Contact us for more information about advertising.
Advertising Terms and Conditions: All ads are reviewed for correct usage, and must be approved prior to publication. Gene Therapy Net reserves the right to refuse advertising privileges to any web site for any reason, including the promotion of pornographic products and/or content, the advocating of illegal activities, immoral conduct, plagiarism, cheating, etc. Gene Therapy Net shall not be held responsible for grammatical errors, typographical errors, or errors in artwork provided by the advertiser. All ads are at the discretion of Gene Therapy Net. All rates are agreed on before advertisement is placed. Your ad will be place after full payment has been received. When an order has been received and payment taken for the service there will be no refund to the advertiser. Gene Therapy Net reserves the right to modify, change or otherwise improve upon the design and format of any or all of its pages at any time without notice. Gene Therapy Net reserves the right to modify, eradicate and/or change any or all of these terms and conditions without notice, including the right to change the above rates or to terminate this advertising program. We appreciate, but do not require, reciprocal links to Gene Therapy Net to be posted on your site.
Suggestions
Gene Therapy News
- Ocugen: Progress in Gene Therapy and Financial Outlook - TipRanks
Sat, 09 Nov 2024 05:22:3 GMT - Cell And Gene Therapy Market Size to Hit US$ 132.6 Billion by 2030, Coherent Market Insights - BioSpace
Fri, 08 Nov 2024 18:09:4 GMT - Belief Biomed’s gene therapy for DMD designated orphan drug in US - BioWorld Online
Fri, 08 Nov 2024 15:00:0 GMT - Pediatric Gene Therapy Workgroup honored for defining personalized care for children - VUMC Reporter
Thu, 07 Nov 2024 22:59:0 GMT - Sarepta scraps a Duchenne drug as gene therapy sales rise - BioPharma Dive
Thu, 07 Nov 2024 17:27:2 GMT - What’s coming up at Cell & Gene Therapy International Europe 2024? - RegMedNet
Thu, 07 Nov 2024 17:14:5 GMT - Navigating Payer Challenges in Cell and Gene Therapy - Journal of Clinical Pathways
Thu, 07 Nov 2024 16:37:4 GMT - Cell And Gene Therapy Market Size to Worth USD 190.82 Billion by 2033 | Straits Research - GlobeNewswire
Thu, 07 Nov 2024 15:31:3 GMT - Lung Cancer Awareness Month 2024: Looking Back at Progress for Cell and Gene Therapy - CGTLive™
Thu, 07 Nov 2024 14:18:4 GMT - FDA eases the way for cell and gene therapy companies - BioWorld Online
Thu, 07 Nov 2024 14:00:0 GMT - ScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy - PR Newswire
Thu, 07 Nov 2024 13:00:0 GMT - Ring Therapeutics calls on Singapore research agencies for gene therapy R&D partnership - Fierce Biotech
Wed, 06 Nov 2024 15:59:4 GMT - Stem cells can tailor their role in gene therapy based on the underlying disease, study suggests - Medical Xpress
Wed, 06 Nov 2024 13:20:0 GMT - Gene Therapy Developer Beam Therapeutics Reports One Patient Death In Early-Stage Sickle Cell Disease Trial - Yahoo Finance
Tue, 05 Nov 2024 21:37:3 GMT - iotaSciences launches fast single-cell cloning platform for gene therapy - European Pharmaceutical Manufacturer
Tue, 05 Nov 2024 17:42:1 GMT